Thus, this study was designed to investigate the association between Gly482Ser polymorphism within the PPARGC1A gene and increased susceptibility to NAFLD in Iranian subjects. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.